vimarsana.com

Page 6 - தொற்று நோய்கள் பகுப்பாய்வு ஆராய்ச்சி அலகு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19 Vaccine: Wits trial results published in New England Journal

Covid-19 Vaccine: Wits trial results published in New England Journal The complete analysis of the trial indicates that there may be a modest protective effect of prior exposure to the original Covid-19 strain. New England Journal of Medicine (NEJM). Wits University announced in a statement on Thursday that the NEJM, recognised as the world’s leading medical journal, had published the findings of the Phase 2b clinical trial conducted at Wits University in South Africa. The article was published on 5 May. Shabir Madhi, Professor of Vaccinology, co-author of the study, and the Director of the Vaccines & Infectious Diseases Analytics Research Unit (Wits VIDA), led the Novavax Covid-19 vaccine trial in SA.

2021-05 - Novavax Covid-19 vaccine trial results show efficacy against the B 1 351 variant in SA study

5 May 2021 - Wits University Results from the initial primary analysis of the Novavax Covid-19 vaccine trial conducted by Wits VIDA in SA have been published. The New England Journal of Medicine (NEJM) today published findings of the Phase 2b clinical trial conducted in South Africa. NEJM is recognised as the world’s leading medical journal. Shabir Madhi, Professor of Vaccinology, co-author of the study, and the Director of the Vaccines & Infectious Diseases Analytics Research Unit (Wits VIDA), led the Novavax Covid-19 vaccine trial in South Africa. The published data provide additional detail of an initial analysis conducted in January, while more robust data from a complete analysis of the study was subsequently shared in March 2021.

Latest - Novavax Covid-19 vaccine trial results show efficacy against the B 1 351 variant in SA study

5 May 2021 - Wits University Results from the initial primary analysis of the Novavax Covid-19 vaccine trial conducted by Wits VIDA in SA have been published. The New England Journal of Medicine (NEJM) today published findings of the Phase 2b clinical trial conducted in South Africa. NEJM is recognised as the world’s leading medical journal. Shabir Madhi, Professor of Vaccinology, co-author of the study, and the Director of the Vaccines & Infectious Diseases Analytics Research Unit (Wits VIDA), led the Novavax Covid-19 vaccine trial in South Africa. The published data provide additional detail of an initial analysis conducted in January, while more robust data from a complete analysis of the study was subsequently shared in March 2021.

Covid-19 is here to stay

Covid-19 is here to stay Barloworld calls on social entrepreneurs to apply for 2021/22 Barloworld MbewuSocial entrepreneurs are invited to submit their entries for consideration for incubation to the second leg of a Barloworld flagship entrepreneurial programme known as Mbewu. The entries for the 2021/2022 programme are open and close on 14 May 2021. New Amazon Africa headquarters to be built in Cape TownUS retail giant Amazon will be the anchor tenant of a R4bn River Club development that has gotten the go-ahead from the City of Cape Town. Smash burger dispute: Rocomamas to meet with food truck ownerRocoMamas will meet with Cape Town-based Rack n Grill food truck owner Muammer Kasu on 20 April, after the burger franchise was called out for corporate bullying tactics when it demanded that the small takeaway business refrains from using the term Smash Burger on its menu.

SA and its tax trouble – how do we fix the problem?

We need to acknowledge that our tax systems have been decimated by years of mismanagement and getting the right capabilities in place now is key. SA has immensely competent individuals who are more than capable of playing their role in this process, but do we have the political will to do so? SA undoubtedly has a long road ahead before its taxpayers will feel they are getting ‘value for money’. Judge Dennis Davis is the next guest in the PSG Think Big webinar series, and he will be talking to series host and acclaimed journalist Bruce Whitfield about the real challenges facing the country when it comes to tax collection. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.